NEOG
NEOGEN CORP
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$11.63
−1.52%Next report
Analyst consensus
- Next report date
- Jan 14, 2027
- EPS estimate
- $0.07
- Revenue estimate
- $224.8M
Latest reported
- Last report date
- Oct 6, 2026
- EPS actual
- $0.08
- EPS estimate
- $0.05
- Revenue actual
- $222.8M
- Revenue estimate
- $207.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +69.4%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $14
- PT range
- $14 – $14
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 6, 2026 | $0.05 | $0.08 | Beat 50.94% | $222.8M |
| Jul 30, 2026 | $0.06 | $0.09 | Beat 58.81% | $225.3M |
| Apr 9, 2026 | $0.04 | $0.09 | Beat 125.00% | $211.2M |
| Jan 8, 2026 | $0.07 | $0.10 | Beat 42.86% | $224.7M |
| Oct 9, 2025 | -$0.07 | $0.04 | Beat 154.05% | $209.2M |
| Apr 9, 2025 | $0.13 | $0.10 | Miss -23.08% | $221.0M |
| Jan 10, 2025 | $0.09 | $0.11 | Beat 22.22% | $231.3M |
| Oct 10, 2024 | $0.09 | $0.07 | Miss -17.65% | $217.0M |
| Jul 30, 2024 | $0.12 | $0.10 | Miss -16.67% | $236.8M |
| Apr 9, 2024 | $0.14 | $0.12 | Miss -14.29% | $228.8M |
| Jan 9, 2024 | $0.15 | $0.11 | Miss -26.67% | $229.6M |
| Oct 10, 2023 | $0.14 | $0.11 | Miss -21.43% | $229.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jan 14, 2027